Maxtra P DS Syrup
By Maxtra P
Rx
60ml Syrup in a Bottle

Composition
Chlorpheniramine Maleate(2mg) + Paracetamol(250mg) + Phenylephrine(5mg)

Manufacturer - Zuventus Healthcare Ltd
Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (E), Mumbai - 400 072.

Expires on or after
September, 2025

liver
When taking Maxtra P DS Syrup, individuals with liver disease should be cautious. It may be necessary to adjust the dosage of the syrup in such cases. To ensure safe use, it is advised to consult with your doctor before using Maxtra P DS Syrup.

kidney
Maxtra P DS Syrup is generally considered safe for patients with kidney disease. Dose adjustment may not be necessary, but caution is advised as it can lead to increased drowsiness in those with end stage kidney disease. Please consult your doctor.

alcohol
It is unsafe to drink alcohol while taking Maxtra P DS Syrup.

driving
Maxtra P DS Syrup may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Maxtra P DS Syrup may not be safe to use during pregnancy, as animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks.

breastfeeding
Maxtra P DS Syrup is likely safe during breastfeeding based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹123.75
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024